ResearchTecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial
ResearchViral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study
Feb 9, 2026Journal ArticleMpox in People With HIV: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite Cohort.Written by 1 Roon author & 22 others Via Clinical Infectious Diseases
Feb 26, 2026Original ArticleTecovirimat for the Treatment of MpoxWritten by 2 Roon authors & 25 others Via The New England Journal of Medicine
ResearchCorrection: How would Marie Kondo design a protocol? In favor of subtractive change in clinical trials
ResearchPitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis
ResearchAssessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device
ResearchImpact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-Elicited SARS-CoV-2 Immune Responses
ResearchA novel injectable drug-combination nanoparticle containing three antiretrovirals designed for HIV treatment: A first-in-human trial
Oct 28, 2026Journal ArticleFurther Unraveling the Association Between HIV, Immune Suppression, and Cancer Survival.Written by 1 Roon author & 1 other Via Clinical Infectious Diseases
Feb 4, 2026Journal ArticleShort Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.Written by 2 Roon authors & 18 others Via Clinical Infectious Diseases
ResearchRapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy